Sign in →

Test Code REVE0 Erythrocytosis Summary Interpretation

Testing Algorithm

When 1 or more molecular tests are added to the REVE2 / Erythrocytosis Evaluation, Blood, then this test is also added as consultative interpretation that summarizes the testing performed as well as any pertinent clinical information. This summary is in addition to interpretations that may be provided for each component. This will be provided after additional testing is complete in order to incorporate subsequent results into an overall evaluation.

Method Name

Only orderable as a reflex. For more information see REVE2 / Erythrocytosis Evaluation, Blood.

 

Medical Interpretation

Specimen Type

Whole Blood EDTA

Specimen Stability Information

Specimen Type Temperature Time
Whole Blood EDTA Refrigerated

Clinical Information

The etiology of congenital (inherited) erythrocytosis can be due to one of several abnormalities. This includes high oxygen affinity hemoglobin variants, genetic variants in the erythropoietin receptor gene, genetic variants in the genes involved in the oxygen-sensing pathway (PHD2/EGLN1, HIF2A/EPAS1, VHL) or BPGM variants causing 2,3-BPG (2,3-bisphosphoglycerate) deficiency. To determine the underlying abnormality frequently requires molecular testing. A summary interpretation that incorporates all testing performed is beneficial to the ordering clinician.

Reference Values

Only orderable as a reflex. For more information see REVE2 / Erythrocytosis Evaluation, Blood.

 

An interpretive report will be provided.

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Day(s) Performed

Monday through Friday

Report Available

3 to 25 days